- Home
- IPHA vs MDV Comparison
IPHA vs MDV Comparison
Compare IPHA & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- MDV
- Stock Information
- Founded
- IPHA 1999
- MDV 2015
- Country
- IPHA France
- MDV United States
- Employees
- IPHA N/A
- MDV N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- MDV Transportation Services
- Sector
- IPHA Health Care
- MDV Consumer Discretionary
- Exchange
- IPHA Nasdaq
- MDV Nasdaq
- Market Cap
- IPHA 160.1M
- MDV 147.6M
- IPO Year
- IPHA 2019
- MDV 2022
- Fundamental
- Price
- IPHA $1.82
- MDV $14.63
- Analyst Decision
- IPHA Strong Buy
- MDV
- Analyst Count
- IPHA 3
- MDV 0
- Target Price
- IPHA $5.00
- MDV N/A
- AVG Volume (30 Days)
- IPHA 572.8K
- MDV 28.4K
- Earning Date
- IPHA 09-17-2025
- MDV 11-14-2025
- Dividend Yield
- IPHA N/A
- MDV 8.18%
- EPS Growth
- IPHA N/A
- MDV N/A
- EPS
- IPHA N/A
- MDV N/A
- Revenue
- IPHA $14,839,695.00
- MDV $47,479,000.00
- Revenue This Year
- IPHA $22.29
- MDV $1.67
- Revenue Next Year
- IPHA $43.84
- MDV $2.14
- P/E Ratio
- IPHA N/A
- MDV N/A
- Revenue Growth
- IPHA N/A
- MDV N/A
- 52 Week Low
- IPHA $1.41
- MDV $13.62
- 52 Week High
- IPHA $3.51
- MDV $17.15
- Technical
- Relative Strength Index (RSI)
- IPHA 42.84
- MDV 45.78
- Support Level
- IPHA $1.73
- MDV $14.41
- Resistance Level
- IPHA $1.86
- MDV $14.85
- Average True Range (ATR)
- IPHA 0.12
- MDV 0.28
- MACD
- IPHA -0.02
- MDV 0.02
- Stochastic Oscillator
- IPHA 11.51
- MDV 34.09
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.